AI and nanotechnology could make cancer cell therapy affordable for all

(Credit: Unsplash)

This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum.

Author: Professor Liesbet Lagae, Director of Life Science Technology Activities at IMEC and teaches Nanobiotechnology, KU Leuven


  • CAR-T therapy can cure terminally ill cancer patients but it is prohibitively expensive, costing hundreds of thousands of dollars.
  • Leveraging recent advances in chip technology scientists can create and mass produce small machines to re-engineer the immune system.
  • But the scientific community needs public-private partnerships to ensure this medical breakthrough becomes accessible to everyone.

After suffering 16 months of chemotherapy for her leukaemia, treatment options for six-year-old Emily Whitehead had run out. Her parents began to fear the worst. As a last-ditch effort, the University of Pennsylvania enrolled Emily in a clinical trial that involved reprogramming her immune cells to destroy her cancer. The results were phenomenal. Emily not only survived, but nine years later she is a healthy teenager with no cancer.

Behind Emily’s recovery is CAR-T (Chimeric Antigen Receptor T cells ) a cell-based therapy that has become a revolutionary weapon in the treatment of previously incurable blood cancers.

CAR-T cell therapy genetically modifies a patient’s immune cells to hunt and kill cancer cells. It is a form of personalized immunotherapy that can provide lasting remissions, even to terminally ill patients who have just months to live and for whom classic treatment options have not worked.

More than 400 clinical trials of CAR-T therapies are currently in progress. Their impact could be enormous. According to the World Health Organization, cancer causes one in six deaths worldwide. Personalized cell therapy has the potential to save millions of lives. Preliminary data even suggests that engineering immune cells may one day be used to treat heart failure, autoimmune diseases, diabetes and HIV.

Why does CAR-T cost so much?

But unit economics are hobbling the rollout of CAR-T to the full number of patients whose lives it could save. The treatment alone can cost up to $475,000 and US hospitals can charge as much as $1.5 million to administer it, once ancillary costs are taken into account.

So why this high price? With conventional therapies, drug makers get economies of scale: the more they produce, the cheaper each dose becomes.

But CAR-T is tailor-made for each patient, and behind every treatment lies a highly sophisticated process, which is time-consuming and brutally expensive. https://player.vimeo.com/video/54668275?title=1&byline=1&portrait=1&autoplay=0

The patient’s immune cells are collected, purified in various steps, genetically modified, formulated at the right dose and reinfused. This complex manufacturing process requires shipments to different labs and frequent manual interventions, which introduce the risk of human error and potentially life-threatening side effects. Compounded by the fact that CAR-T consists of living cells that vary in potency, manufacturers need to continuously test results throughout the process.

The result is a production time that can take weeks, and an unaffordable price. Unless these economics change, this treatment will not reach patients whose lives it could save – it will only reach those privileged enough to afford it.

Technology holds the key to reducing costs

There is, however, hope. The most recent insights in nanotechnology, artificial intelligence (AI), biosensors, and the Internet of Things could help overcome the current roadblocks in making personalized cell therapies affordable.

The solution to democratize these therapies lies in automating their manufacturing process, which would reduce the cost, time, and risks significantly. This will require several engineering breakthroughs but is technically possible.

Recent advances in chip technology provide inspiration. The modern world’s insatiable demand for better computers, gaming consoles, and smartphones has resulted in the extreme miniaturization of transistors – the components which drive technology’s processing capacity – as more transistors on smaller circuits enables new and stronger technological abilities. healthcare

What is the World Economic Forum doing about healthcare value and spending?

Each year, $3.2 trillion is spent on global healthcare making little or no impact on good health outcomes.

To address this issue, the World Economic Forum created the Global Coalition for Value in Healthcare to accelerate value-based health systems transformation.

This council partners with governments, leading companies, academia, and experts from around the world to co-design and pilot innovative new approaches to person-centered healthcare.

Enormous capital spending has gone into chip engineering, resulting in the development of materials and systems on scales so small a new window of opportunities opens up: the ability to screen, select, and even genetically modify cells.

If we leverage these techniques to advance medical research, modern technology holds the potential to create and mass produce small machines that are able to re-engineer the immune system. The result would be a true revolution in the treatment of diseases, unparalleled in effectiveness and safety.

What can governments do?

Speaking on behalf of the research community, we see four ways governments can accelerate progress:

  • Invest in infrastructure that supports joint technology and clinical R&D.
  • Allow us to work together more easily.
  • Harmonize regulations.
  • Provide longer-term research grants.

Various small scale infrastructure investments have already been made. By aligning strategies and pooling resources, governments can advance research dramatically.

The conventional approach to develop drug candidates that split discovery, clinical trials and manufacturing will not work as pharmaceutical companies are faced with the novel challenge of re-engineering living cells, which requires new and highly advanced manufacturing processes.

Programmes will therefore need to be designed in which both knowledge and infrastructure are shared simultaneously, allowing medical researchers to use technology they would otherwise not be able to access, while letting engineers further develop it.

Building the right ecosystems in which the necessary skill sets are combined will be crucial for these therapies’ overall success. Interdisciplinary collaboration between life scientists and experts in AI and nanoelectronics will be needed, as well as partnerships between pharmaceutical and technology companies.

Legislators should update and harmonize policies when possible to ensure restrictive regulations do not stall technological progress and consider reforming science funding. Even top academics can spend as much as half their time writing out applications for short-term grants. It is wasted time they are not spending in the lab.

Both US President Joe Biden and EU Commission President Ursula von der Leyen have pledged to rid the world of cancer. But any plan that does not include a detailed roadmap on how to make CAR-T therapy affordable is bound to fail.

Patient-derived cell therapies have the potential of saving lives when conventional approaches fail. However, with a price tag of hundreds of thousands of dollars for a single treatment, these therapies will remain far from accessible. The world is counting on its leaders to build the public-private partnerships that will ensure this significant medical breakthrough becomes accessible to everyone who needs it.

the sting Milestones

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

The EU Diplomacy in North Korea promotes peace or war?

The Chinese retail revolution is heading west

UN health agency spotlights stalled effort to close health divide across Europe, in new report

State aid: Commission approves €520 million Italian scheme to compensate the trade fairs and congress sector for damages suffered due to the coronavirus outbreak

COVID-19 vaccines: EU must respond with unity and solidarity

Financial transactions tax gets go ahead

This company lets you set your own salary

The different ways of care: Is there a general rule to follow?

EU Trade Ministers come together in a desperate attempt to save TTIP

CLIMATE CHANGE FOCUS: Tunisia coastline in need of climate cash boost

Mental health in the context of a pandemic: social distance

Why is black plastic packaging so hard to recycle?

Logo Mania: A call to action to our crisis of connection

These 5 foods are under threat from climate change

EU economic governance: More exploitation for the weaker countries

The next talent opportunity for the digital workplace? Neurodiversity

An economist explains how to go carbon neutral in our lifetime

Deaths from far-right terrorism have more than tripled in the West

The cost of dying

What Europe’s SMEs need to do for a cyber-secure future

How long will people live in the future?

Insurer CEOs Reveal Marketing Strategies that Communicate the True Value of Insurance Products & Services to the Customer

UNESCO lists wrestling, reggae and raiho-shin rituals as global treasures to be preserved

In Mozambique, it’s ‘a matter of the heart’ says Guterres, lauding the cyclone-struck nation’s ‘undeniable moral authority’

China in My Suburbs

Coronavirus: Commission launches data sharing platform for researchers

Environment and health at increasing risk from growing weight of ‘e-waste’

Health spending set to outpace GDP growth to 2030

Aviation Strategy for Europe: Commission signs landmark aviation agreements with China

The impact of mobile and rapid digital adoption on how India consumes

Coronavirus: Commission adopts new exceptional support measures for the wine sector

Europe eyes to replace US as China’s prime foreign partner

Women in leadership: closing the gender gap in medicine

UN launches plan to promote peace, inclusive growth in Africa’s Sahel

Libya on verge of civil war, threatening ‘permanent division’, top UN official warns Security Council

Global public-private collaboration tackles cybersecurity skills gap

Finland is a world leader in clean energy. Here’s what’s driving its success

Iceland’s slowdown underlines the need to fix structural issues

The new era of Matriarchy?

UN political chief calls for dialogue to ease tensions in Venezuela; Security Council divided over path to end crisis

How to create a world where healthcare is a right, not a luxury

Accelerating a more sustainable industrial revolution with digital manufacturing

EU Budget 2021 deal: supporting the recovery

Blockchain is not a magic bullet for security. Can it be trusted?

6 ways data sharing can shape a better future

Millions of Afghans have ‘voted not just for a president, but also for democracy’, UN Assembly told

Doctors are humans too: the benefits of embracing your mental status

‘No shortcuts to a healthier world’: WHO chief sets out health priorities for the decade

G7 summit: Trump Vs. G6 leaders on trade and climate change

How China Mended My Heart

How AI can accelerate the search for treatments for emerging and intractable diseases

European Union disenchanted with Turkey

These are the biggest hurdles on the path to clean energy

UN chief welcomes possibility of resumed talks between US and North Korea

Global Trade Identity can be the cornerstone of paperless trade

Sahel and Central Africa: €210 million in EU humanitarian aid

Innovative finance tools could protect cities from climate change

The DNA of the future retail CEO

EU adopts new €100 million assistance package to benefit refugees and local communities in Lebanon, Jordan, and Iraq

Strict alcohol laws which cut intake more than 40 per cent in Russia, linked to historically high life expectancy

More Stings?

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s